To test the hypothesis that neuronal-derived FKN can ameliorate neurodegeneration in a mouse model of STZ-induced diabetes, vectors expressing sFKN or mFKN were delivered intra-vitreally in the retina. Here, CX3CL1 is linked to diabetes mellitus.